SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.200
+0.130 (4.23%)
Oct 28, 2026, 4:00 PM EDT - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $291.16 million as of October 28, 2026. It is the 18,263rd most valuable company in the world and the 3,233rd biggest in the United States. Its market cap has increased by 118.10% in one year.
Market Cap
291.16M
Enterprise Value
193.66M
1-Year Change
118.10%
Global Rank
Country Rank
#3,233 United States
Category
ChartMarket Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $291.16M, an increase of 122.67%. That is a compound annual growth rate of 15.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 292.07M | 64.04% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 263.56M |
| Vogenx | 257.59M |
| Century Therapeutics | 257.13M |
| Bicycle Therapeutics | 255.47M |
| Lineage Cell Therapeutics | 252.12M |
| Q32 Bio | 251.55M |
| Greenwich LifeSciences | 251.36M |
| Rocket Pharmaceuticals | 250.29M |